DiŠerences in the coagulation andˆbrinolytic system of rats fed aˆsh oil based diet (ˆsh oil diet) and fed a soybean oil based diet (control diet) were determined. Concentrations of plasma lipids were depressed in rats fed theˆsh oil diet. Prothrombin time (PT) and activated partial thromboplastin time (APTT) of rats fed thê sh oil diet were longer than for the rats fed the control diet. Fish oil intake lowered the activities of most of the blood coagulation factors, and strongly depressed the factors involved in the intrinsic pathway. Fish oil also aŠected theˆbrinolysis of rats. Plasminogen activator inhibitor (PAI) activity was elevated in rats fed theˆsh oil diet. In this study, both blood coagulation and brinolysis were down-regulated by feeding theˆsh oil diet.
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1) The prevention of clot formation has become a crucial issue in medical and health care for elderly people. Some factors are known to in‰uence blood coagulation, constituents of foods like vitamin-K and vitamin-E, [2] [3] [4] hormonal agents like estrogen, 5, 6) or immune functional compounds like tumor necrosis factor a. 7) Some correlations betweenˆbrinolytic or coagulation parameters and daily habits such as alcohol drinking, smoking, and nutrient intake have been observed. [8] [9] [10] Epidemiological studies have suggested that people with a heavy dependence onˆsh-eating have less risk of heart disease, hyperlipidemia, and atherosclerosis than people with a heavy dependence on meat-eating. 11) Eskimos have a prolonged bleeding time and low risk of hyperlipidemia and coronary heart disease, and this has been suggested as a consequence of the large amount ofˆsh intake, especiallŷ sh oil. 12, 13) The eŠects ofˆsh oil or n-3 polyunsaturated fatty acids on blood coagulation andˆbrinolysis have been examined. [14] [15] [16] [17] [18] [19] [20] [21] However, the mechanism by which they have eŠects on hypocoagulant activity remains unclear. Adhesion of platelets is the trigger of blood coagulation, and the coagulation cascade is activated on the platelets. There are two main pathways of the blood coagulation cascade: intrinsic pathway and extrinsic pathway. These two pathways converge on a common pathway and end up withˆbrin formation. The intrinsic pathway is started with the contact system and includes coagulation factors XII (FXII), FXI, FIX, FVIII. The extrinsic pathway is started with a tissue factor, and includes FVII. In association withˆsh orˆsh oil intake, the activities of coagulation factors II, V, and VII are relatively well documented, but the activities of coagulation factors involved in the intrinsic pathway have been less well investigated. The blood coagulation is complex and involves many factors that interact. Some coagulation factors have blood coagulation activating ability and also converse activity. [22] [23] [24] [25] Thus, it is di‹cult to determine weather blood coagulation as a whole is increased or not with the limited information on the various factors involved in the blood coagulation and brinolytic system. So we did an experiment to analyze most of the factors involved in the coagulation cascade andˆbrinolysis to enable a comprehensive as possible assessment of blood coagulation in rats fed experimental diets.
In this report, we investigated the eŠects ofˆsh oil on the blood coagulation andˆbrinolytic system comparing rats fed theˆsh oil diet to rats fed the control diet.
Materials and Methods
Maleˆve-week-old Sprague-Dawley rats obtained from the Charles River (Kanagawa, Japan) were kept in an air-conditioned room (temperature: 20-229 C; humidity: 55-65z; lighting: 0700-1900), and they were fed on a commercial nonpuriˆed diet (Type NMF; Oriental Yeast Co., Tokyo, Japan) for 1 week. After acclimation to the housing conditions, the rats were divided into two dietary groups; control group andˆsh oil group. The control diet was prepared according to the recommendations of the American Institute of Nutrition (AIN-93G) 26) and theˆsh oil diet was made withˆsh oil substituted for soybean oil in the composition of the control diet (7z of total volume). All the other ingredients in the two types of diets were of equal amounts. The care and treatment of the experimental animals conformed to the National Research Institute of Fisheries Science guidelines for the ethical treatment of laboratory animals.
After free feeding of the experimental diets for 2 weeks, rats were lightly anesthetized with diethyl ether and blood samples were withdrawn from the abdominal aorta into plastic syringes containing 3.8z sodium citrate solution (1 W 9 volume of the blood) and collected into plastic tubes. Plasma samples were obtained by centrifugation (for 30 minutes at 2000 g) and kept frozen until the day of measurements. Blood samples were collected in alternate shifts for each experimental group to exclude the time relevance of various factors.
Plasma lipids were measured with commercially available kits using the enzymatic method (Wako, Japan). Plasmin-a2-plasmin inhibitor complexes (PIC) and D-dimer were measured by latex agglutination (International Reagents Corporation, Japan). 27, 28) PT, APTT,ˆbrinogen, and the activities of the coagulation factors (II, V, VII, X, VIII, IX, XI, and XII) were measured using CA-50 and clinical diagnostic agents (Sysmex, Japan). The CA-50 is a measuring device for coagulation, which can detect the change of turbidity by the dispersion of light when brinogen is converted toˆbrin. PT was measured with thromboplastin (from rabbit brain) and the time ofˆbrin formation was detected. 29) APTT was measured with cephalin (phosphatidylethanolamine) from rabbit brain. 30) Fibrinogen was measured in the presence of excess thrombin. Theˆbrinogen concentration of each sample was calculated from the time taken for coagulation compared to the reference standard.
31) The activities of the coagulation factors were measured by using coagulation-factor-deˆcient plasma. For the factors included both in the extrinsic pathway and in the common pathway (II, V, VII, and X), PT reagent (thromboplastin) and the appropriate factor-deˆcient plasma were used. For the factors included in the intrinsic pathway (VIII, IX, XI, and XII), APTT reagent (actin: cephalin from rabbit brain) and appropriate factor-deˆcient plasma were used. And the activity of each sample was expressed as the percentage of the pooled plasma of the control group.
FXIII activity was measured by the method previously described by Anwar et al. with some modiˆcations.
32) The following reagents used in this assay,ˆbrinogen, thrombin, streptavidinalkalinephosphatase (SAAP), and p-nitrophenyl phosphate (pNPP) were purchased from Sigma and 5-(Biotinamido) pentylamine from Pierce Biotechnology Inc., IL. A reference standard curve was obtained by plotting serial dilution of the pooled control plasma and the activity of FXIII expressed as a percentage of the control.
Antithrombin III (AT III) and a2-plasmin inhibitor were measured by using commercially available kits (Chromogenix, Italy). AT III activity was assessed using S-2238 (H-D-phenylalanyl-L-pipecolyl-Larginyl-p-nitroanilide･2HCl) which is the substrate of thrombin and produces optically detectable pnitroaniline. AT III activity was measured from remaining thrombin activity compared to a reference standard in the presence of an excess of thrombin. a2-Plasmin inhibitor activity was measured using a substrate of plasmin (S-2251; H-D-valyl-L-leucyl-Llysyl-p-nitroanilide･2HCl). When an excess amount of plasmin and S-2251 are added to plasma, plasmin forms an inactive complex with a2-plasmin inhibitor (PIC) and the remaining plasmin reacts with the substrate S-2251 and the amount of released p-nitroaniline indicates the activity of remaining plasmin. Adding certain amounts of excess plasmin to the plasma samples, a2-plasmin inhibitor activity is measured from the remaining plasmin activity. The absorbance was read at 405 nm and the a2-plasmin inhibitor activity was calculated by comparison with the standard serum.
PAI activity was measured for its inhibitory activity against tissue-type plasminogen activator (t-PA) in the presence of t-PA and substrate S-2288 (H-D-IlePro-Arg-p-nitroanilide･2HCl (Chromogenix), which releases p-nitroaniline cleaved by t-PA). Thromboxane B2 (TXB2) and 6-keto-prostaglandin F1a (6kPGF1a) were measured using commercially available ELISA kits (Neogen Corp.).
Results
During the experimental period, no signiˆcant diŠerence was observed in the growth and food intake of rats between the two dietary groups. Theˆnal body weight was 285.2±2.6 g in the control group and 291.3±3.7 g in theˆsh oil group. And the average of their food intake throughout the experimental period was 24.6±0.12 g and 24.3±0.17 g par day, respectively. All statistical analyses were done with student's t-test between the two dietary groups.
Lipid concentration
Plasma concentrations of triacylglycerol and phospholipid and cholesterol were signiˆcantly lower in theˆsh oil group than the control group (Table 1) .
Blood coagulation PT, APTT, andˆbrinogen concentration were measured ( Table 2 ). PT and APTT of theˆsh oil group were signiˆcantly longer than that of the control group. There was no signiˆcant diŠerence in the plasma concentration ofˆbrinogen between the two dietary groups. The activities of the blood coagulation factors were measured. The activities of all the measured factors in rats fedˆsh oil were lower than that of the control group rats (Fig. 1) .
Fibrinolytic parameters and AT III PIC, D-dimer, PAI, a2-plasmin inhibitor, and AT III were measured (Table 3) . No signiˆcant diŠerence was observed between the two diet groups in measured values of PIC and D-dimer. The activities of PAI and plasmin inhibitor were elevated signiˆcantly in theˆsh oil fed group.
TXB2 and 6kPGF1a
We measured the plasma level of TXB2 and the 6kPGF1a level to estimate the levels of thromboxane A2 (TXA2) and prostaglandin I2 (PGI2), respectively. Concentrations of TXB2 and 6kPGF1a were both signiˆcantly decreased in rats fed theˆsh oil diet (Table 4) .
Discussion
There is a growing interest in the functionality of n-3 polyunsaturated fatty acids to modulate health and disease. There have been reported evidence of modulatory eŠects and prevention of diseases such as coronary heart disease, stroke, autoimmune disorders, Crohn's disease, rheumatoid arthritis, and some kinds of cancer.
34) The eŠects of n-3 polyunsaturated fatty acids on lipid metabolism are well documented and the mechanisms of reducing serum lipids have been reported. 35, 36) As in these reports, the plasma concentrations of lipids were found in this study to be strikingly suppressed in rats fed theˆsh oil diet.
Both PT (which indicates the extrinsic pathway coagulation activity) and APTT (which indicates the intrinsic pathway coagulation activity) were elongated signiˆcantly byˆsh oil feeding. This means that sh oil has a hypocoagulant ability and the activity of some coagulation factors might be depressed. Then, we measured the activity of each coagulation factor. The coagulation factor activities were generally lower in rats fed theˆsh oil diet and it was notable in factors involved in the intrinsic pathway. As most of the coagulation factors are produced in the liver, we tested to see if theˆsh oil caused damage to the liver. However, theˆbrinogen concentration of the two dietary groups were found to have the same level, and no elevation was observed in the levels of gglutamyl transpeptidase (g-GTP), glutamate oxaloacetate transaminase (GOT), and glutamate pyruvate transaminase (GPT), used as markers of liver damage (data not shown). So, it is considered that theˆsh oil rich diet in‰uenced the rat blood coagulation without causing damage to the liver. Several reports have examined the eŠects ofˆsh oil on blood coagulation, Nieuwenhuys et al. and Leray et al. suggested that the hypocoagulant eŠects ofˆsh oil were caused by reduction of the vitamin-K-dependent coagulation factor. 37, 38) In this study, we found that most of the coagulation factors were depressed and it was very signiˆcant in the intrinsic pathway. It has been reported that high levels of factor VIII and factor IX, which are included in intrinsic pathway, increase the risk of thrombosis. 39, 40) Thus,ˆsh oil may have beneˆcial eŠects for the control of this type of disease by controlling plasma levels of these factors.
Fibrinogen, solubleˆbrin monomer (converted fromˆbrinogen by thrombin), and insolubleˆbrin polymer (cross-linked by FXIII) are all decomposed by plasmin. D-dimer is the degradation product ofˆb rin polymer. The D-dimer level indicates the amount of producedˆbrin polymer and its decomposition by plasmin. And PIC increases with excessive amounts of plasmin. Although no signiˆcant diŠer-ence was seen in the PIC and D-dimer concentrations, signiˆcant elevation of PAI activity was found in theˆsh oil group compared to the control group. The elevated PAI activity suggests the lowered activity ofˆbrinolysis. We speculate that the activity of a2-plasmin inhibitor also increased for the reduction of the activity of plasmin.
Byberg et al. reported that dietary intake of unsaturated fatty acids is positively associated with PAI-1, the main physiological inhibitor of plasminogen activator, in human.
41) It has also been reported that PAI-1 activity is correlated with the amount of VLDL and adipose tissue. 42, 43) In this study, the adipose tissue weight of the rats fed theˆsh oil diet was signiˆcantly lower than the rats fed the control diet (data not shown), VLDL was also speculated to be lower in the rats fed theˆsh oil diet from the signiˆcant reduction of triacylglycerol in plasma, 44) and PAI activity was elevated. These results are contradictory but it is considered that n-3 polyunsaturated fatty acids directly increased PAI-1 in this study, as unsaturated fatty acids reported to increase PAI-1 in vitro. 45, 46) The eŠects of n-3 polyunsaturated fatty acids upon cyclooxygenase activity and biosynthesis of eicosanoids have been well documented. 47) In our study, the level of eicosanoids also changed dramatically. TXA2 has platelet aggregation activity, and PGI2 can inhibit platelet aggregation. TXA2 and PGI2 are both unstable and readily metabolized into TXB2 and 6kPGF1a, respectively. Hence, low levels of TXA 2 and PGI 2 were observed in the plasma of the rats fed theˆsh oil diet. Plasma TXB2 level of theˆsh-oil-diet-fed rats was 45z lower than that of the control-diet-fed rats and the 6kPGF1a level of theˆsh-oil-diet-fed rats was 58z lower than that of the rats fed the control diet. The decrease of the 6kPGF1a level was larger than the TXB2 level, and the ratio of 6kPGF1a W TXB2 was larger in the rats fed theˆsh oil diet. So platelet aggregation activity of the rats fed theˆsh oil diet is speculated to be lower than the control-diet-fed rats.
In this study, the following eŠects ofˆsh oil were conˆrmed; lipid-lowering activity, reduction of plasma coagulation factor level, reduction ofˆbrinolysis speculated from increased PAI activity. So that lipids are involved in blood coagulation, reduced blood coagulation factor activities might be correlated with the reduction of the plasma lipid level. Our research has expanded the possibility thatˆsh oil has beneˆ-cial eŠects, in the point ofˆnding reduction of the intrinsic coagulation factors.
In conclusion,ˆsh oil rich in n-3 polyunsaturated fatty acids can act as a modulator of blood coagulation andˆbrinolysis. So as rats and humans have a similar mechanism of blood coagulation andˆbrinol-ysis, this is also expected to be applicable to human. Thus, habitually taking food likeˆsh, shellˆsh, or seaweed, rich in n-3 polyunsaturated fatty acids, is expected to be eŠective to prevent thrombus diseases.
